Contents

Current Drug Targets, Volume 4 - Number 3

Preface

, 4(3): i

Martin Tenniswood


DOI: 10.2174/1389450033491172




Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

, 4(3): 191 - 196

Aristotelis G. Anastasiadis, Debra L. Bemis, Brian C. Stisser, Laurent Salomon, Mohamed A. Ghafar and Ralph Buttyan


DOI: 10.2174/1389450033491136




TGF-ß / Smad Signaling in Prostate Cancer

, 4(3): 197 - 207

Diana Bello-DeOcampo and Donald J. Tindall


DOI: 10.2174/1389450033491118




Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer

, 4(3): 209 - 221

Martin Gleave, Colleen Nelson and Kim Chi


DOI: 10.2174/1389450033491190




Par-4 for Molecular Therapy of Prostate Cancer

, 4(3): 223 - 230

James Butler and Vivek M. Rangnekar


DOI: 10.2174/1389450033491163




Phytoestrogens and Prostate Cancer

, 4(3): 231 - 241

Colm Morrissey and R. William G. Watson


DOI: 10.2174/1389450033491154




From TGF-β to Cancer Therapy

, 4(3): 243 - 250

Xuemei Huang and Chung Lee


DOI: 10.2174/1389450033491181




Therapeutic Targets for Metastatic Prostate Cancer

, 4(3): 251 - 261

Terry L. Timme, Takefumi Satoh, Salahaldin A. Tahir, Hongyu Wang, Bin S. The, E. Brian Butler, Brian J. Miles, Robert J. Amato, Dov Kadmon and Timothy C. Thompson


DOI: 10.2174/1389450033491127




Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer

, 4(3): 263 - 279

W. C. Powell, R. D. Cardiff, M. B. Cohen, G. J. Miller and P. Roy-Burman


DOI: 10.2174/1389450033491145




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science